Comparative Formulation Study of Vabicaserin

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

This study will compare two different formulations of vabicaserin.

Key facts

Study ID

NCT00928551

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

15

Starts

2009-06-01

Expected to finish

2009-09-01

Last updated by the study team

2009-09-11

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Sexually active men must agree to use a medically acceptable form of contraception during the study and continue it for 12 weeks after investigational product administration.
• Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Must be able to abstain from smoking during the inpatient stay.

You may not qualify if…

• Use of any investigational or prescription drug within 30 days before investigation product administration.
• Consumption of any caffeine-containing products (eg, coffee, tea, chocolate, or soda) or alcoholic beverages within 48 hours before study day 1.
• Use of any over-the-counter drugs, including herbal supplements within 72 hours before study day 1.

Where it is running

• Study site — Brighton, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.